Castres, France

Philippe Chopin


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Philippe Chopin: Innovator in Medicinal Chemistry

Introduction

Philippe Chopin is a notable inventor based in Castres, France. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on triazinones. His research focuses on developing new compounds that can be utilized as effective medicaments.

Latest Patents

Philippe Chopin holds a patent for "5-monoaryl as.-triazin-3-ones substituted in 2-position, and their use." This invention concerns new 5-monoaryl as.-triazin-3-ones, which are substituted in the 2-position. The patent outlines a method for preparing these compounds and their application as medicaments. The compounds have a general formula that includes an optional double bond, indicating their versatility in medicinal applications.

Career Highlights

Chopin is associated with Pierre Fabre Medicament, a company known for its commitment to pharmaceutical innovation. His work has contributed to the development of new therapeutic agents that can address various medical conditions. With a focus on practical applications, his inventions aim to improve patient outcomes through advanced medicinal chemistry.

Collaborations

Philippe Chopin has collaborated with notable colleagues such as Guy Pitet and Henri Cousse. These partnerships have fostered a collaborative environment that enhances the research and development of new medicinal compounds.

Conclusion

Philippe Chopin's contributions to medicinal chemistry through his innovative patents and collaborations highlight his role as a key inventor in the field. His work continues to pave the way for advancements in pharmaceutical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…